Get started
Author

A. Marlijn Waaijers

Observed names: A M Waaijers, A Marlijn Waaijers, A. M. Waaijers, AM Waaijers, a.m. Waaijers
Institution: Erasmus MC
OpenAlex ID: A5113675109
Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
2008 · C de Bruin, R A Feelders, et al. · Journal of Molecular Endocrinology · 86
Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion
2011 · C. de Bruin, L. J. Hofland, et al. · The Journal of Clinical Endocrinology & Metabolism · 58
Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
2013 · R. van der Pas, R. A. Feelders, et al. · The Journal of Clinical Endocrinology & Metabolism · 51
17- -Estradiol-Dependent Regulation of Somatostatin Receptor Subtype Expression in the 7315b Prolactin Secreting Rat Pituitary Tumor in Vitro and in Vivo
1997 · H. A. Visser-Wisselaar, C. J. C. van Uffelen, et al. · Endocrinology · 49
PDF
IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
2019 · Maria Cristina De Martino, Peter M. van Koetsveld, et al. · Endocrine · 39
PDF
Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s Disease
2008 · C. de Bruin, J. M. Hanson, et al. · Endocrinology · 35
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors
2014 · Maria Cristina De Martino, Richard A Feelders, et al. · Endocrine Related Cancer · 28
PDF
Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue
2014 · Stephanie Booy, Leo J. Hofland, et al. · Pancreas · 9
Somatostatin and Dopamine Receptor (Co-)Expression in Neuroendocrine Tumors with Ectopic ACTH Production: Potential Targets for Medical Treatment.
2010 · RA Feelders, C de Bruin, et al. · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego · 1
Evaluation of New Possible Molecular Predictors for Clinical Response to Somatostatin Analog Treatment in Patients with GH-Secreting Adenomas
2011 · Federico Gatto, Richard A Feelders, et al. · The Endocrine Society eBooks
Normalization of Cortisol Levels in Cushing Disease after Medical Pretreatment before Surgery: Consequences for Somatostatin Receptor Subtype Expression andIn VitroResponse to Somatostatin Analogs
2011 · Rob van der Pas, Richard A Feelders, et al. · The Endocrine Society eBooks
The demethylating agent 5-aza-2-deoxycytidine upregulates somatostatin type 2 receptor expression and enhances internalization of radiolabeled somatostatin analogue in human carcinoid tumour cells
2011 · Marije J Veenstra, Koetsveld P M van, et al. · 13th European Congress of Endocrinology
Novel Specific Kinase Receptor Activation Bioassays for the Human Insulin Receptor A (IR-A) and B (IR-B) To Study the Insulin-IGF System.
2010 · AJ Varewijck, MP Brugts, et al. · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego
Growth Hormone Receptor mRNA Expression and GH Production with and without Pegvisomant in Somatotroph Pituitary Adenomas.
2010 · s.j.c.m.m. Neggers, m. Bidlingmaier, et al. · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego
Works count: 14
Citation count: 356
H-index: 8
I10-index: 7
Year
Topic
Type